Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2010
12/28/2010US7858344 Compositions of aminoacyl-tRNA synthetase and uses thereof
12/28/2010US7858343 Method for production of a heterologous protein using yeast-type host cells
12/28/2010US7858342 for sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
12/28/2010US7858341 using an E. coli expression system for the large scale production of FGF18 (fibroblast growth factors); improved methods for producing biologically active and purified recombinant FGF18
12/28/2010US7858340 Polynucleotides and methods of directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cells
12/28/2010US7858339 Refractile particles containing a heterologous polypeptide as an insoluble aggregate are recovered from bacterial periplasm; allows use of phage lysozyme at high cell density and increased scale; Chloroform is not used in any step and the recovery step minimizes co-recovery of cellular debris
12/28/2010US7858338 Processing enzymes fused to basic protein tags
12/28/2010US7858337 Process for the manufacture of a composite material
12/28/2010US7858335 Microorganisms and assays for the identification of antibiotics
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/28/2010US7858088 chimeric anti-EGP-2-binding scFv fragment 4D5MOC-A; for treatment of human carcinomas; Pseudomonas exotoxin A
12/28/2010US7858087 enhancing the complement mediated cytotoxic activity ofchimeric anti-CD20 monoclonal antibody IDEC-C2B8 (RITUXIMAB) for its target cells by contacting with the antibody; and with a donor complement protein either as fresh plasma/sera or as isolated complement components
12/23/2010WO2010147900A1 IMPROVEMENT OF LONG CHAIN OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACID BIOSYNTHESIS BY EXPRESSION OF ACYL-CoA LYSOPHOSPHOLIPID ACYLTRANSFERASES
12/23/2010WO2010147835A1 Zymomonas with improved arabinose utilization
12/23/2010WO2010147111A1 Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method
12/23/2010US20100325744 Non-glycosylated recombinant monovalent antibodies
12/23/2010US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation
12/23/2010US20100324170 Microcapsule-type latent curing agent
12/23/2010US20100323971 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323905 Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates
12/23/2010US20100323448 Methods For Producing Biological Substances In Enzyme-Deficient Mutants Of Aspergillus niger
12/23/2010US20100323401 General method for generating human antibody responses in vitro
12/23/2010US20100323400 Compositions and Methods for Controlling Copy Number for a Broad Range of Plasmids and Uses Thereof
12/23/2010US20100323399 Use of Trail Polypeptides to Treat Cancer
12/23/2010US20100323398 Baculoviruses With Enhanced Virion Production and a Method for the Production of Baculoviruses
12/23/2010US20100323397 Modified vird2 protein and its use in improved gene transfer
12/23/2010US20100323366 Methods of Selecting a Dopaminergic Neuron Proliferative Progenitor Cells Using LRP4/CORIN Markers
12/23/2010US20100323364 MODIFIED tRNA CONTAINING UNNATURAL BASE AND USE THEREOF
12/23/2010US20100322977 Biomaterials, compositions, and methods
12/23/2010US20100322975 Anti-bacterial Vaccine Compositions
12/23/2010US20100322956 Methods and substances for the treatment of alzheimer's
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322937 EGF receptor epitope peptides and uses thereof
12/23/2010US20100322935 Tri- or Tetraspecific Antibodies
12/23/2010US20100322934 Bispecific, Tetravalent Antigen Binding Proteins
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322929 Antigen presenting cell targeted cancer vaccines
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/22/2010EP2264178A1 Vaccinia virus host range genes to increase the titer of Avipoxviruses
12/22/2010EP2264177A1 A method for manufacturing glycoproteins having human-type glycosylation
12/22/2010EP2264176A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/22/2010EP2264175A1 Fibroblast growth factor homologs
12/22/2010EP2264174A2 Protein similar to neuroendocrine-specific protein, and encoding CDNA
12/22/2010EP2264166A2 Method for controlling the activity of immunologically functional molecule
12/22/2010EP2264163A2 Methods of modifying eukaryotic cells
12/22/2010EP2264156A1 Phytases
12/22/2010EP2264152A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
12/22/2010EP2264151A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
12/22/2010EP2264071A1 Antibody having an immune-enhancement function
12/22/2010EP2264070A1 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264052A2 Activatable recombinant neurotoxins
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
12/22/2010EP2264045A1 Stable compositions for nucleic acid amplification and sequencing
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
12/22/2010EP2263684A1 IL-21 derivatives
12/22/2010EP2262892A2 Expression of heterologous sequences
12/22/2010EP2262837A2 Pd-1 binding proteins
12/22/2010EP2262832A1 Monoclonal antibodies for ebola and marburg viruses
12/22/2010EP2262829A1 A new type of consensus interferon and preparation method thereof
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
12/22/2010EP1135496B1 Ucp5
12/22/2010CN101925819A Immunodetection assay for mycobacterium tuberculosis complex
12/22/2010CN101925674A Improved bioactive peptide production
12/22/2010CN101921821A Method for extracting high-quality collagen at low temperature
12/22/2010CN101921820A Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof
12/22/2010CN101921819A Expression and purification system using recombinant protein as label
12/22/2010CN101921818A Method for producing recombinant protein A
12/22/2010CN101921798A Method for preparing gene recombinant human ferritin light chain
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921712A Yeast stain for producing astaxanthin and glutathione by fermentation method and production process thereof
12/22/2010CN101921339A Soluble-expression influenza virus hemagglutinin HA2 fusion protein
12/22/2010CN101921336A Monoclonal antibody against human alpha1 acid glycoprotein and preparation method thereof
12/22/2010CN101921332A Recombinant human insulin and production method thereof
12/22/2010CN101921330A Recombinant human interferon alpha 1b mutant and preparation method thereof
12/22/2010CN101921328A Antifreeze polypeptide prepared by enzymolysis of cow leather collagen by alkali protease
12/22/2010CN101921318A Method for preparing antifreeze polypeptide through enzymolysis of pigskin collagen protein by utilizing alkali protease
12/22/2010CN101921317A Anti-freeze polypeptide prepared by utilizing papain to carry out enzymolysis to pigskin collagen
12/22/2010CN101921316A Frost-resisting polypeptide prepared by using pigskin collagen
12/22/2010CN101921315A Artificially synthesized signal peptide and application thereof
12/22/2010CN101921311A Anti-freeze polypeptide prepared by enzymolysis of cow leather collagen through papain
12/22/2010CN101289507B Collagen protein and collagen polypeptides, preparation thereof and applications
12/22/2010CN101280333B Method for preparing penicillium antibacterial peptide from grey rose penicillium
12/22/2010CN101273129B Recombinant vector capable of increasing secretion of koji mold protease
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855276 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells
12/21/2010US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors
12/21/2010US7855167 In vivo screening of protein-protein interactions with protein-fragment complementation assays
12/21/2010US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
12/21/2010US7855065 Mutant bacterium belonging to the genus Bacillus
12/21/2010US7855060 Transgenic escherichia for use as bioreactor for fermentation of amino acids for use in medicine, cosmetics and animal feeds
12/21/2010US7855058 Human cyclin-dependent kinase (hPNQALRE)
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 1125